Symbols / BAX $15.80 -1.06% Baxter International Inc.
BAX Chart
About
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Instruments & Su | Market Cap | 8.16B |
| Enterprise Value | 15.92B | Income | -900.00M | Sales | 11.24B |
| Book/sh | 11.92 | Cash/sh | 3.82 | Dividend Yield | 225.00% |
| Payout | 3.08% | Employees | 37500 | IPO | — |
| P/E | — | Forward P/E | 7.70 | PEG | — |
| P/S | 0.73 | P/B | 1.33 | P/C | — |
| EV/EBITDA | 7.89 | EV/Sales | 1.42 | Quick Ratio | 1.31 |
| Current Ratio | 2.31 | Debt/Eq | 160.28 | LT Debt/Eq | — |
| EPS (ttm) | -1.73 | EPS next Y | 2.05 | EPS Growth | — |
| Revenue Growth | 8.00% | Earnings | 2026-04-30 | ROA | 2.83% |
| ROE | -13.71% | ROIC | — | Gross Margin | 35.73% |
| Oper. Margin | 7.36% | Profit Margin | -8.51% | Shs Outstand | 516.25M |
| Shs Float | 512.19M | Short Float | 11.02% | Short Ratio | 3.44 |
| Short Interest | — | 52W High | 34.52 | 52W Low | 15.73 |
| Beta | 0.55 | Avg Volume | 9.89M | Volume | 6.33M |
| Target Price | $22.19 | Recom | Hold | Prev Close | $15.97 |
| Price | $15.80 | Change | -1.06% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-03-11 | main | Citigroup | Neutral → Neutral | $19 |
| 2026-02-17 | main | Goldman Sachs | Neutral → Neutral | $17 |
| 2026-02-13 | main | Barclays | Overweight → Overweight | $25 |
| 2026-01-09 | main | Barclays | Overweight → Overweight | $30 |
| 2025-12-02 | main | Morgan Stanley | Underweight → Underweight | $15 |
| 2025-10-31 | main | Citigroup | Neutral → Neutral | $21 |
| 2025-10-31 | main | Goldman Sachs | Neutral → Neutral | $22 |
| 2025-10-31 | main | UBS | Neutral → Neutral | $21 |
| 2025-10-31 | down | Argus Research | Buy → Hold | — |
| 2025-10-07 | main | Evercore ISI Group | Outperform → Outperform | $31 |
| 2025-08-04 | main | Barclays | Overweight → Overweight | $36 |
| 2025-08-04 | down | Stifel | Buy → Hold | $25 |
| 2025-08-04 | main | UBS | Neutral → Neutral | $24 |
| 2025-08-01 | main | Wells Fargo | Equal-Weight → Equal-Weight | $24 |
| 2025-07-15 | main | Morgan Stanley | Underweight → Underweight | $27 |
| 2025-07-09 | main | Citigroup | Neutral → Neutral | $32 |
| 2025-07-08 | main | Evercore ISI Group | Outperform → Outperform | $42 |
| 2025-05-05 | main | Morgan Stanley | Underweight → Underweight | $28 |
| 2025-05-02 | main | Wells Fargo | Equal-Weight → Equal-Weight | $33 |
| 2025-03-10 | main | Barclays | Overweight → Overweight | $41 |
News
RSS: Latest BAX news- Baxter International Inc (BAX) Stock Price Down 4.2% on Mar 30 - GuruFocus Mon, 30 Mar 2026 18
- Baxter rolls out barcode IV labels aimed at cutting bedside errors - Stock Titan Mon, 30 Mar 2026 12
- Sticking With Baxter At The Lows (NYSE:BAX) - Seeking Alpha Fri, 06 Mar 2026 08
- 3 Reasons to Avoid BAX and 1 Stock to Buy Instead - Yahoo Finance Fri, 27 Mar 2026 16
- A Look At Baxter International (BAX) Valuation As CFO Transition Draws Investor Attention - simplywall.st Fri, 27 Mar 2026 06
- EU regulator flags Baxter cancer drug shortage until early next year - Reuters ue, 24 Mar 2026 20
- BofA reiterates Baxter stock rating at Neutral on CFO transition - Investing.com Mon, 16 Mar 2026 07
- BAXTER INTERNATIONAL INC ($BAX) Former Chair of the Board, President and CEO 2025 Pay Revealed - Quiver Quantitative Mon, 23 Mar 2026 21
- Reasons to Retain Baxter International Stock in Your Portfolio Now - Zacks Investment Research Fri, 26 Dec 2025 08
- Baxter investors get online-only annual meeting, with voting on May 5 - Stock Titan Wed, 25 Mar 2026 20
- Why Baxter (BAX) Stock Is Trading Lower Today - Yahoo Finance Mon, 12 Jan 2026 08
- BAX SEC Filings - Baxter Intl Inc 10-K, 10-Q, 8-K Forms - Stock Titan Fri, 27 Mar 2026 14
- How Is Baxter's Stock Performance Compared to Other Medical Devices Stocks? - Yahoo Finance Wed, 18 Mar 2026 07
- [SCHEDULE 13G/A] BAXTER... - Stock Titan hu, 26 Mar 2026 20
- Therapy animals will reach 100,000 patients and care teams in pilot - Stock Titan Wed, 25 Mar 2026 13
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
11,244.00
+5.72%
|
10,636.00
+2.66%
|
10,360.00
+3.01%
|
10,057.00
|
| Operating Revenue |
|
11,244.00
+5.72%
|
10,636.00
+2.66%
|
10,360.00
+3.01%
|
10,057.00
|
| Cost Of Revenue |
|
7,865.00
+18.24%
|
6,652.00
+7.12%
|
6,210.00
-4.58%
|
6,508.00
|
| Reconciled Cost Of Revenue |
|
7,865.00
+18.24%
|
6,652.00
+7.12%
|
6,210.00
-4.58%
|
6,508.00
|
| Gross Profit |
|
3,379.00
-15.19%
|
3,984.00
-4.00%
|
4,150.00
+16.93%
|
3,549.00
|
| Operating Expense |
|
3,202.00
-9.68%
|
3,545.00
+2.96%
|
3,443.00
-3.88%
|
3,582.00
|
| Research And Development |
|
518.00
-12.20%
|
590.00
+13.90%
|
518.00
+15.11%
|
450.00
|
| Selling General And Administration |
|
2,890.00
-2.60%
|
2,967.00
+0.47%
|
2,953.00
-4.65%
|
3,097.00
|
| General And Administrative Expense |
|
—
|
2,967.00
-24.66%
|
3,938.00
+27.16%
|
3,097.00
|
| Salaries And Wages |
|
—
|
—
|
-42.00
-61.54%
|
-26.00
|
| Other Gand A |
|
—
|
2,967.00
-24.66%
|
3,938.00
+27.16%
|
3,097.00
|
| Other Operating Expenses |
|
-206.00
-1616.67%
|
-12.00
+57.14%
|
-28.00
-180.00%
|
35.00
|
| Total Expenses |
|
11,067.00
+8.53%
|
10,197.00
+5.64%
|
9,653.00
-4.33%
|
10,090.00
|
| Operating Income |
|
177.00
-59.68%
|
439.00
-37.91%
|
707.00
+2242.42%
|
-33.00
|
| Total Operating Income As Reported |
|
-308.00
-2300.00%
|
14.00
-98.02%
|
707.00
+124.85%
|
-2,845.00
|
| EBITDA |
|
766.00
-31.36%
|
1,116.00
-35.64%
|
1,734.00
+198.36%
|
-1,763.00
|
| Normalized EBITDA |
|
1,261.00
-19.32%
|
1,563.00
-13.84%
|
1,814.00
+64.91%
|
1,100.00
|
| Reconciled Depreciation |
|
981.00
-1.60%
|
997.00
+1.32%
|
984.00
-8.21%
|
1,072.00
|
| EBIT |
|
-215.00
-280.67%
|
119.00
-84.13%
|
750.00
+126.46%
|
-2,835.00
|
| Total Unusual Items |
|
-495.00
-10.74%
|
-447.00
-458.75%
|
-80.00
+97.21%
|
-2,863.00
|
| Total Unusual Items Excluding Goodwill |
|
-495.00
-10.74%
|
-447.00
-458.75%
|
-80.00
+97.21%
|
-2,863.00
|
| Special Income Charges |
|
-478.00
-12.47%
|
-425.00
-1150.00%
|
-34.00
+98.82%
|
-2,877.00
|
| Other Special Charges |
|
-16.00
|
—
|
1.00
-98.15%
|
54.00
|
| Impairment Of Capital Assets |
|
485.00
+14.12%
|
425.00
|
0.00
-100.00%
|
2,812.00
|
| Restructuring And Mergern Acquisition |
|
—
|
—
|
-19.00
+51.28%
|
-39.00
|
| Write Off |
|
9.00
|
0.00
-100.00%
|
34.00
|
0.00
|
| Net Income |
|
-957.00
-47.46%
|
-649.00
-124.44%
|
2,656.00
+209.17%
|
-2,433.00
|
| Pretax Income |
|
-505.00
-74.74%
|
-289.00
-219.42%
|
242.00
+107.45%
|
-3,248.00
|
| Net Non Operating Interest Income Expense |
|
-238.00
+30.21%
|
-341.00
+22.32%
|
-439.00
-11.42%
|
-394.00
|
| Interest Expense Non Operating |
|
290.00
-28.92%
|
408.00
-19.69%
|
508.00
+23.00%
|
413.00
|
| Net Interest Income |
|
-238.00
+30.21%
|
-341.00
+22.32%
|
-439.00
-11.42%
|
-394.00
|
| Interest Expense |
|
290.00
-28.92%
|
408.00
-19.69%
|
508.00
+23.00%
|
413.00
|
| Interest Income Non Operating |
|
52.00
-22.39%
|
67.00
-2.90%
|
69.00
+263.16%
|
19.00
|
| Interest Income |
|
52.00
-22.39%
|
67.00
-2.90%
|
69.00
+263.16%
|
19.00
|
| Other Income Expense |
|
-444.00
-14.73%
|
-387.00
-1388.46%
|
-26.00
+99.08%
|
-2,821.00
|
| Other Non Operating Income Expenses |
|
51.00
-15.00%
|
60.00
+11.11%
|
54.00
+28.57%
|
42.00
|
| Gain On Sale Of Security |
|
-17.00
+22.73%
|
-22.00
+52.17%
|
-46.00
-428.57%
|
14.00
|
| Gain On Sale Of Business |
|
—
|
0.00
|
0.00
+100.00%
|
-65.00
|
| Tax Provision |
|
395.00
+967.57%
|
37.00
-39.34%
|
61.00
+145.19%
|
-135.00
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
-16.67%
|
0.00
+500.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-103.95
-10.74%
|
-93.87
-365.63%
|
-20.16
+83.23%
|
-120.25
|
| Net Income Including Noncontrolling Interests |
|
-957.00
-50.00%
|
-638.00
-123.96%
|
2,663.00
+210.00%
|
-2,421.00
|
| Net Income From Continuing Operation Net Minority Interest |
|
-900.00
-167.06%
|
-337.00
-293.68%
|
174.00
+105.57%
|
-3,125.00
|
| Net Income From Continuing And Discontinued Operation |
|
-957.00
-47.46%
|
-649.00
-124.44%
|
2,656.00
+209.17%
|
-2,433.00
|
| Net Income Continuous Operations |
|
-900.00
-176.07%
|
-326.00
-280.11%
|
181.00
+105.81%
|
-3,113.00
|
| Net Income Discontinuous Operations |
|
-57.00
+81.73%
|
-312.00
-112.57%
|
2,482.00
+258.67%
|
692.00
|
| Minority Interests |
|
0.00
+100.00%
|
-11.00
-57.14%
|
-7.00
+41.67%
|
-12.00
|
| Normalized Income |
|
-508.95
-3255.30%
|
16.13
-93.10%
|
233.84
+161.18%
|
-382.25
|
| Net Income Common Stockholders |
|
-957.00
-47.46%
|
-649.00
-124.44%
|
2,656.00
+209.17%
|
-2,433.00
|
| Diluted EPS |
|
-1.87
-47.24%
|
-1.27
-124.19%
|
5.25
+208.70%
|
-4.83
|
| Basic EPS |
|
-1.87
-47.24%
|
-1.27
-124.19%
|
5.25
+208.70%
|
-4.83
|
| Basic Average Shares |
|
513.00
+0.59%
|
510.00
+0.79%
|
506.00
+0.40%
|
504.00
|
| Diluted Average Shares |
|
513.00
+0.59%
|
510.00
+0.79%
|
506.00
+0.40%
|
504.00
|
| Diluted NI Availto Com Stockholders |
|
-957.00
-47.46%
|
-649.00
-124.44%
|
2,656.00
+209.17%
|
-2,433.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
20,055.00
-22.21%
|
25,782.00
-8.82%
|
28,276.00
-0.04%
|
28,287.00
|
| Current Assets |
|
6,872.00
-22.38%
|
8,853.00
-7.78%
|
9,600.00
+19.84%
|
8,011.00
|
| Cash Cash Equivalents And Short Term Investments |
|
1,966.00
+11.45%
|
1,764.00
-42.69%
|
3,078.00
+79.16%
|
1,718.00
|
| Cash And Cash Equivalents |
|
1,966.00
+11.45%
|
1,764.00
-42.69%
|
3,078.00
+79.16%
|
1,718.00
|
| Receivables |
|
1,932.00
+11.68%
|
1,730.00
-2.37%
|
1,772.00
-32.44%
|
2,623.00
|
| Accounts Receivable |
|
1,861.00
+10.84%
|
1,679.00
-2.33%
|
1,719.00
-33.14%
|
2,571.00
|
| Gross Accounts Receivable |
|
1,924.00
+9.94%
|
1,750.00
-1.74%
|
1,781.00
-33.67%
|
2,685.00
|
| Allowance For Doubtful Accounts Receivable |
|
-63.00
+11.27%
|
-71.00
-14.52%
|
-62.00
+45.61%
|
-114.00
|
| Other Receivables |
|
71.00
+39.22%
|
51.00
-3.77%
|
53.00
+1.92%
|
52.00
|
| Inventory |
|
2,232.00
+9.09%
|
2,046.00
+6.67%
|
1,918.00
-28.41%
|
2,679.00
|
| Raw Materials |
|
536.00
+5.10%
|
510.00
-3.77%
|
530.00
-24.07%
|
698.00
|
| Work In Process |
|
369.00
+38.72%
|
266.00
+13.68%
|
234.00
-20.41%
|
294.00
|
| Finished Goods |
|
1,327.00
+4.49%
|
1,270.00
+10.05%
|
1,154.00
-31.59%
|
1,687.00
|
| Prepaid Assets |
|
261.00
-28.69%
|
366.00
+13.66%
|
322.00
-13.67%
|
373.00
|
| Current Deferred Assets |
|
—
|
—
|
—
|
—
|
| Assets Held For Sale Current |
|
0.00
-100.00%
|
2,611.00
+19.83%
|
2,179.00
+823.31%
|
236.00
|
| Hedging Assets Current |
|
0.00
-100.00%
|
8.00
-82.22%
|
45.00
+221.43%
|
14.00
|
| Other Current Assets |
|
481.00
+46.65%
|
328.00
+14.69%
|
286.00
-22.28%
|
368.00
|
| Total Non Current Assets |
|
13,183.00
-22.13%
|
16,929.00
-9.35%
|
18,676.00
-7.89%
|
20,276.00
|
| Net PPE |
|
3,186.00
+0.31%
|
3,176.00
-0.97%
|
3,207.00
-38.75%
|
5,236.00
|
| Gross PPE |
|
8,330.00
+4.73%
|
7,954.00
-0.40%
|
7,986.00
-29.46%
|
11,321.00
|
| Accumulated Depreciation |
|
-5,144.00
-7.66%
|
-4,778.00
+0.02%
|
-4,779.00
+21.46%
|
-6,085.00
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Land And Improvements |
|
119.00
+3.48%
|
115.00
-3.36%
|
119.00
-13.14%
|
137.00
|
| Buildings And Improvements |
|
1,402.00
+7.76%
|
1,301.00
+5.09%
|
1,238.00
-29.54%
|
1,757.00
|
| Machinery Furniture Equipment |
|
5,454.00
+8.06%
|
5,047.00
+2.81%
|
4,909.00
-22.86%
|
6,364.00
|
| Construction In Progress |
|
704.00
-1.95%
|
718.00
+15.06%
|
624.00
-31.35%
|
909.00
|
| Other Properties |
|
651.00
-15.78%
|
773.00
-29.47%
|
1,096.00
-49.12%
|
2,154.00
|
| Goodwill And Other Intangible Assets |
|
9,298.00
-11.43%
|
10,498.00
-10.36%
|
11,711.00
-11.58%
|
13,245.00
|
| Goodwill |
|
4,929.00
-6.56%
|
5,275.00
-8.94%
|
5,793.00
-10.21%
|
6,452.00
|
| Other Intangible Assets |
|
4,369.00
-16.35%
|
5,223.00
-11.74%
|
5,918.00
-12.88%
|
6,793.00
|
| Investments And Advances |
|
103.00
-5.50%
|
109.00
-19.85%
|
136.00
-44.94%
|
247.00
|
| Non Current Accounts Receivable |
|
126.00
-4.55%
|
132.00
-14.29%
|
154.00
-27.01%
|
211.00
|
| Non Current Deferred Assets |
|
200.00
-1.96%
|
204.00
-22.43%
|
263.00
-6.07%
|
280.00
|
| Non Current Deferred Taxes Assets |
|
200.00
-1.96%
|
204.00
-22.43%
|
263.00
-6.07%
|
280.00
|
| Other Non Current Assets |
|
204.00
-92.59%
|
2,754.00
-12.82%
|
3,159.00
+238.22%
|
934.00
|
| Total Liabilities Net Minority Interest |
|
13,953.00
-25.62%
|
18,758.00
-5.30%
|
19,808.00
-11.54%
|
22,392.00
|
| Current Liabilities |
|
2,970.00
-54.38%
|
6,511.00
+0.12%
|
6,503.00
+37.05%
|
4,745.00
|
| Payables And Accrued Expenses |
|
2,182.00
+8.02%
|
2,020.00
+1.97%
|
1,981.00
-19.11%
|
2,449.00
|
| Payables |
|
1,183.00
-7.00%
|
1,272.00
+6.18%
|
1,198.00
-20.56%
|
1,508.00
|
| Accounts Payable |
|
999.00
+3.20%
|
968.00
+9.88%
|
881.00
-20.63%
|
1,110.00
|
| Other Payable |
|
—
|
—
|
—
|
—
|
| Dividends Payable |
|
5.00
-94.25%
|
87.00
-40.82%
|
147.00
+0.68%
|
146.00
|
| Current Accrued Expenses |
|
999.00
+33.56%
|
748.00
-4.47%
|
783.00
-16.79%
|
941.00
|
| Employee Benefits |
|
637.00
-6.05%
|
678.00
-5.04%
|
714.00
-15.60%
|
846.00
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
436.00
-10.29%
|
486.00
-5.45%
|
514.00
+12.47%
|
457.00
|
| Total Tax Payable |
|
179.00
-17.51%
|
217.00
+27.65%
|
170.00
-32.54%
|
252.00
|
| Income Tax Payable |
|
83.00
-31.40%
|
121.00
+55.13%
|
78.00
-14.29%
|
91.00
|
| Current Debt And Capital Lease Obligation |
|
84.00
-97.03%
|
2,832.00
+2.65%
|
2,759.00
+81.04%
|
1,524.00
|
| Current Debt |
|
3.00
-99.89%
|
2,752.00
+3.19%
|
2,667.00
+89.96%
|
1,404.00
|
| Other Current Borrowings |
|
3.00
-99.89%
|
2,752.00
+3.19%
|
2,667.00
+89.96%
|
1,404.00
|
| Current Capital Lease Obligation |
|
81.00
+1.25%
|
80.00
-13.04%
|
92.00
-23.33%
|
120.00
|
| Current Deferred Liabilities |
|
141.00
+7.63%
|
131.00
+2.34%
|
128.00
-16.88%
|
154.00
|
| Current Deferred Revenue |
|
141.00
+7.63%
|
131.00
+2.34%
|
128.00
-16.88%
|
154.00
|
| Other Current Liabilities |
|
127.00
-87.81%
|
1,042.00
-7.05%
|
1,121.00
+596.27%
|
161.00
|
| Total Non Current Liabilities Net Minority Interest |
|
10,983.00
-10.32%
|
12,247.00
-7.95%
|
13,305.00
-24.60%
|
17,647.00
|
| Liabilities Heldfor Sale Non Current |
|
0.00
-100.00%
|
554.00
+0.54%
|
551.00
+359.17%
|
120.00
|
| Long Term Debt And Capital Lease Obligation |
|
9,696.00
-8.67%
|
10,617.00
-6.49%
|
11,354.00
-27.58%
|
15,679.00
|
| Long Term Debt |
|
9,473.00
-8.69%
|
10,374.00
-6.45%
|
11,089.00
-27.20%
|
15,232.00
|
| Long Term Capital Lease Obligation |
|
223.00
-8.23%
|
243.00
-8.30%
|
265.00
-40.72%
|
447.00
|
| Long Term Provisions |
|
31.00
+6.90%
|
29.00
+52.63%
|
19.00
-5.00%
|
20.00
|
| Defined Pension Benefit |
|
66.00
+17.86%
|
56.00
+21.74%
|
46.00
-62.60%
|
123.00
|
| Non Current Pension And Other Postretirement Benefit Plans |
|
637.00
-6.05%
|
678.00
-5.04%
|
714.00
-15.60%
|
846.00
|
| Tradeand Other Payables Non Current |
|
146.00
+55.32%
|
94.00
+30.56%
|
72.00
+12.50%
|
64.00
|
| Non Current Deferred Liabilities |
|
281.00
+96.50%
|
143.00
-67.79%
|
444.00
-36.66%
|
701.00
|
| Non Current Deferred Revenue |
|
36.00
-10.00%
|
40.00
-2.44%
|
41.00
+2.50%
|
40.00
|
| Non Current Deferred Taxes Liabilities |
|
245.00
+137.86%
|
103.00
-74.44%
|
403.00
-39.03%
|
661.00
|
| Other Non Current Liabilities |
|
192.00
+45.45%
|
132.00
-12.58%
|
151.00
-30.41%
|
217.00
|
| Stockholders Equity |
|
6,129.00
-11.99%
|
6,964.00
-17.11%
|
8,402.00
+44.04%
|
5,833.00
|
| Common Stock Equity |
|
6,129.00
-11.99%
|
6,964.00
-17.11%
|
8,402.00
+44.04%
|
5,833.00
|
| Capital Stock |
|
683.00
+0.00%
|
683.00
+0.00%
|
683.00
+0.00%
|
683.00
|
| Common Stock |
|
683.00
+0.00%
|
683.00
+0.00%
|
683.00
+0.00%
|
683.00
|
| Share Issued |
|
683.49
+0.00%
|
683.49
+0.00%
|
683.49
+0.00%
|
683.49
|
| Ordinary Shares Number |
|
514.28
+0.66%
|
510.93
+0.65%
|
507.63
+0.63%
|
504.43
|
| Treasury Shares Number |
|
169.21
-1.94%
|
172.57
-1.87%
|
175.86
-1.79%
|
179.06
|
| Additional Paid In Capital |
|
6,368.00
-0.83%
|
6,421.00
+0.50%
|
6,389.00
+1.06%
|
6,322.00
|
| Retained Earnings |
|
13,705.00
-8.20%
|
14,929.00
-7.35%
|
16,114.00
+14.69%
|
14,050.00
|
| Gains Losses Not Affecting Retained Earnings |
|
-3,754.00
+6.38%
|
-4,010.00
-12.83%
|
-3,554.00
+7.28%
|
-3,833.00
|
| Treasury Stock |
|
10,873.00
-1.68%
|
11,059.00
-1.52%
|
11,230.00
-1.40%
|
11,389.00
|
| Minority Interest |
|
-27.00
-145.00%
|
60.00
-9.09%
|
66.00
+6.45%
|
62.00
|
| Other Equity Adjustments |
|
-3,754.00
+6.38%
|
-4,010.00
-12.83%
|
-3,554.00
+7.28%
|
-3,833.00
|
| Total Equity Gross Minority Interest |
|
6,102.00
-13.13%
|
7,024.00
-17.05%
|
8,468.00
+43.65%
|
5,895.00
|
| Total Capitalization |
|
15,602.00
-10.01%
|
17,338.00
-11.05%
|
19,491.00
-7.47%
|
21,065.00
|
| Working Capital |
|
3,902.00
+66.61%
|
2,342.00
-24.38%
|
3,097.00
-5.17%
|
3,266.00
|
| Invested Capital |
|
15,605.00
-22.32%
|
20,090.00
-9.33%
|
22,158.00
-1.38%
|
22,469.00
|
| Total Debt |
|
9,780.00
-27.28%
|
13,449.00
-4.70%
|
14,113.00
-17.96%
|
17,203.00
|
| Net Debt |
|
7,510.00
-33.90%
|
11,362.00
+6.41%
|
10,678.00
-28.42%
|
14,918.00
|
| Capital Lease Obligations |
|
304.00
-5.88%
|
323.00
-9.52%
|
357.00
-37.04%
|
567.00
|
| Net Tangible Assets |
|
-3,169.00
+10.33%
|
-3,534.00
-6.80%
|
-3,309.00
+55.36%
|
-7,412.00
|
| Tangible Book Value |
|
-3,169.00
+10.33%
|
-3,534.00
-6.80%
|
-3,309.00
+55.36%
|
-7,412.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
845.00
-17.08%
|
1,019.00
-40.96%
|
1,726.00
+42.53%
|
1,211.00
|
| Cash Flow From Continuing Operating Activities |
|
951.00
+16.12%
|
819.00
-32.15%
|
1,207.00
+128.60%
|
528.00
|
| Cash From Discontinued Operating Activities |
|
-106.00
-153.00%
|
200.00
-61.46%
|
519.00
-24.01%
|
683.00
|
| Net Income From Continuing Operations |
|
-900.00
-176.07%
|
-326.00
-280.11%
|
181.00
+105.81%
|
-3,113.00
|
| Depreciation Amortization Depletion |
|
981.00
-1.60%
|
997.00
+1.32%
|
984.00
-8.21%
|
1,072.00
|
| Depreciation |
|
383.00
+2.96%
|
372.00
-5.58%
|
394.00
+0.25%
|
393.00
|
| Amortization Cash Flow |
|
598.00
-4.32%
|
625.00
+5.93%
|
590.00
-13.11%
|
679.00
|
| Depreciation And Amortization |
|
981.00
-1.60%
|
997.00
+1.32%
|
984.00
-8.21%
|
1,072.00
|
| Amortization Of Intangibles |
|
598.00
-4.32%
|
625.00
+5.93%
|
590.00
-13.11%
|
679.00
|
| Other Non Cash Items |
|
30.00
-26.83%
|
41.00
-33.87%
|
62.00
+255.00%
|
-40.00
|
| Pension And Employee Benefit Expense |
|
-32.00
-14.29%
|
-28.00
+3.45%
|
-29.00
-196.67%
|
30.00
|
| Stock Based Compensation |
|
117.00
+2.63%
|
114.00
-0.87%
|
115.00
-17.86%
|
140.00
|
| Asset Impairment Charge |
|
802.00
+54.53%
|
519.00
+4818.18%
|
-11.00
-100.35%
|
3,165.00
|
| Deferred Tax |
|
77.00
+129.39%
|
-262.00
-2.34%
|
-256.00
+1.54%
|
-260.00
|
| Deferred Income Tax |
|
77.00
+129.39%
|
-262.00
-2.34%
|
-256.00
+1.54%
|
-260.00
|
| Operating Gains Losses |
|
-48.00
-71.43%
|
-28.00
+3.45%
|
-29.00
-117.06%
|
170.00
|
| Net Foreign Currency Exchange Gain Loss |
|
—
|
0.00
|
0.00
-100.00%
|
65.00
|
| Change In Working Capital |
|
-108.00
+54.24%
|
-236.00
-246.58%
|
161.00
+126.57%
|
-606.00
|
| Change In Receivables |
|
-132.00
-277.14%
|
-35.00
+7.89%
|
-38.00
+20.83%
|
-48.00
|
| Changes In Account Receivables |
|
-132.00
-277.14%
|
-35.00
+7.89%
|
-38.00
+20.83%
|
-48.00
|
| Change In Inventory |
|
-119.00
+40.80%
|
-201.00
-57.03%
|
-128.00
+35.35%
|
-198.00
|
| Change In Prepaid Assets |
|
72.00
+157.60%
|
-125.00
-177.78%
|
-45.00
-2.27%
|
-44.00
|
| Change In Payables And Accrued Expense |
|
152.00
-2.56%
|
156.00
-59.48%
|
385.00
+271.11%
|
-225.00
|
| Change In Accrued Expense |
|
149.00
+238.64%
|
44.00
-84.98%
|
293.00
+285.44%
|
-158.00
|
| Change In Payable |
|
3.00
-97.32%
|
112.00
+21.74%
|
92.00
+237.31%
|
-67.00
|
| Change In Account Payable |
|
3.00
-97.32%
|
112.00
+21.74%
|
92.00
+237.31%
|
-67.00
|
| Change In Other Working Capital |
|
-81.00
-161.29%
|
-31.00
-138.46%
|
-13.00
+85.71%
|
-91.00
|
| Investing Cash Flow |
|
2,841.00
+553.83%
|
-626.00
-119.48%
|
3,213.00
+445.11%
|
-931.00
|
| Cash Flow From Continuing Investing Activities |
|
-464.00
-13.17%
|
-410.00
+0.00%
|
-410.00
+34.29%
|
-624.00
|
| Cash From Discontinued Investing Activities |
|
3,305.00
+1630.09%
|
-216.00
-105.96%
|
3,623.00
+1280.13%
|
-307.00
|
| Capital Expenditure |
|
-522.00
-13.48%
|
-460.00
-5.50%
|
-436.00
+31.34%
|
-635.00
|
| Capital Expenditure Reported |
|
-513.00
-15.02%
|
-446.00
-3.24%
|
-432.00
-14.59%
|
-377.00
|
| Net Investment Purchase And Sale |
|
0.00
-100.00%
|
34.00
|
0.00
|
0.00
|
| Sale Of Investment |
|
0.00
-100.00%
|
34.00
|
0.00
|
0.00
|
| Net Business Purchase And Sale |
|
—
|
—
|
-6.00
+97.72%
|
-263.00
|
| Purchase Of Business |
|
—
|
—
|
-6.00
+97.72%
|
-263.00
|
| Gain Loss On Sale Of Business |
|
—
|
0.00
|
0.00
-100.00%
|
75.00
|
| Net Intangibles Purchase And Sale |
|
-9.00
+35.71%
|
-14.00
-250.00%
|
-4.00
+98.45%
|
-258.00
|
| Purchase Of Intangibles |
|
-9.00
+35.71%
|
-14.00
-250.00%
|
-4.00
+98.45%
|
-258.00
|
| Net Other Investing Changes |
|
58.00
+262.50%
|
16.00
-38.46%
|
26.00
+136.36%
|
11.00
|
| Financing Cash Flow |
|
-4,216.00
-290.01%
|
-1,081.00
+69.02%
|
-3,489.00
-142.63%
|
-1,438.00
|
| Cash Flow From Continuing Financing Activities |
|
-4,216.00
-290.01%
|
-1,081.00
+69.02%
|
-3,489.00
-142.63%
|
-1,438.00
|
| Net Issuance Payments Of Debt |
|
-3,791.00
-613.94%
|
-531.00
+81.91%
|
-2,935.00
-226.47%
|
-899.00
|
| Issuance Of Debt |
|
1,998.00
-6.02%
|
2,126.00
|
0.00
-100.00%
|
55.00
|
| Repayment Of Debt |
|
-5,789.00
-117.88%
|
-2,657.00
+9.47%
|
-2,935.00
-207.65%
|
-954.00
|
| Long Term Debt Issuance |
|
1,998.00
|
0.00
|
0.00
|
0.00
|
| Long Term Debt Payments |
|
-5,489.00
-106.59%
|
-2,657.00
-0.87%
|
-2,634.00
-176.10%
|
-954.00
|
| Net Long Term Debt Issuance |
|
-3,491.00
-31.39%
|
-2,657.00
-0.87%
|
-2,634.00
-176.10%
|
-954.00
|
| Short Term Debt Issuance |
|
0.00
-100.00%
|
2,126.00
|
0.00
-100.00%
|
55.00
|
| Short Term Debt Payments |
|
-300.00
|
—
|
-301.00
|
—
|
| Net Short Term Debt Issuance |
|
-300.00
-114.11%
|
2,126.00
+806.31%
|
-301.00
-647.27%
|
55.00
|
| Net Common Stock Issuance |
|
—
|
0.00
|
0.00
+100.00%
|
-32.00
|
| Common Stock Payments |
|
—
|
0.00
|
0.00
+100.00%
|
-32.00
|
| Common Stock Dividend Paid |
|
-348.00
+41.02%
|
-590.00
-0.68%
|
-586.00
-2.27%
|
-573.00
|
| Cash Dividends Paid |
|
-348.00
+41.02%
|
-590.00
-0.68%
|
-586.00
-2.27%
|
-573.00
|
| Repurchase Of Capital Stock |
|
—
|
0.00
|
0.00
+100.00%
|
-32.00
|
| Proceeds From Stock Option Exercised |
|
30.00
-57.75%
|
71.00
-25.26%
|
95.00
-25.20%
|
127.00
|
| Net Other Financing Charges |
|
-107.00
-245.16%
|
-31.00
+50.79%
|
-63.00
-3.28%
|
-61.00
|
| Changes In Cash |
|
-530.00
+22.97%
|
-688.00
-147.45%
|
1,450.00
+225.22%
|
-1,158.00
|
| Effect Of Exchange Rate Changes |
|
84.00
+187.50%
|
-96.00
-469.23%
|
26.00
+134.21%
|
-76.00
|
| Beginning Cash Position |
|
2,414.00
-24.52%
|
3,198.00
+85.71%
|
1,722.00
-41.75%
|
2,956.00
|
| End Cash Position |
|
1,968.00
-18.48%
|
2,414.00
-24.52%
|
3,198.00
+85.71%
|
1,722.00
|
| Free Cash Flow |
|
323.00
-42.22%
|
559.00
-56.67%
|
1,290.00
+123.96%
|
576.00
|
| Interest Paid Supplemental Data |
|
303.00
-24.44%
|
401.00
-17.15%
|
484.00
+36.34%
|
355.00
|
| Income Tax Paid Supplemental Data |
|
—
|
223.00
+28.16%
|
174.00
+3.57%
|
168.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-03-19 View
- 8-K2026-03-16 View
- 42026-03-10 View
- 42026-03-10 View
- 42026-03-10 View
- 42026-03-10 View
- 42026-03-10 View
- 42026-03-03 View
- 42026-03-03 View
- 42026-03-03 View
- 42026-03-03 View
- 42026-03-03 View
- 42026-03-03 View
- 42026-03-03 View
- 42026-02-18 View
- 10-K2026-02-12 View
- 8-K2026-02-12 View
- 42026-02-11 View
- 42026-02-11 View
- 42026-02-11 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|